Where are we seeing signs of life?
In digital health:
- IPOs: AI-driven platforms were the highlight here, with Tempus (precision medicine) and XtalPi (drug R&D) going public in Q2.
- Fat checks: Average deal size in 2024 is $16.7M — up 40% from 2023 — driven by a migration to middle and later-stage deals away from the early stage.
In fintech:
- Crypto & blockchain: Startups here are getting renewed focus, snagging nearly one-third of the top 10 seed and top 10 Series A deals in Q2.
- Big US deals: Nine of the 10 biggest deals in the US were worth $100M or more, the most since Q2’22.
And of course, in the broader venture space, AI is what’s hot.
28% of VC dollars now go to AI startups — the highest quarterly share on record.
Fine dining
Companies developing large language models like GPT-4 want data.
As these companies quickly exhaust what’s publicly available, they’re looking for proprietary information sources to feed their hungry models.
OpenAI is most aggressively licensing content from news publishers and others.
It recently inked a 5-year deal with News Corp for a reported $250M.
Check out the licensing deals done by OpenAI and other big tech players in this report.